Article Text

Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice
  1. C M BATE
  1. Department of Gastroenterology,
  2. Royal Albert Edward Infirmary,
  3. Wigan WN1 2NN, UK

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor,—I was interested to read the paper by Eggleston et al (Gut1998;42:13–16) purporting to show that a “step up” approach using prokinetics and H2 receptor antagonists in the management of gastro-oesophageal reflux disease (GORD) is more cost effective than omeprazole in a general practice setting. I do not think the conclusions drawn are supported by data presented.

The MediPlus database does not permit systematic evaluation of the severity of GORD symptoms and so there is no certainty that the three patient groups (who received omeprazole, ranitidine or cisapride) were comparable. Patients were excluded from the study …

View Full Text